Avita Therapeutics Inc. buy BiotechBee
Start price
24.12.22
/
60%
€6.10
Target price
31.12.25
€9.00
Performance (%)
139.34%
End price
05.05.23
€14.60
Summary
This prediction ended on 05.05.23 with a price of €14.60. With a performance of 139.34% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Avita Therapeutics Inc. | 5.298% | 5.298% | -45.548% |
iShares Core DAX® | -0.922% | -1.078% | 12.165% |
iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to BiotechBee what are the pros and cons of Avita Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Avita Therapeutics Inc. diskutieren
Buy mit Kursziel 9,0
In the thread Trading Avita Therapeutics Inc.
Buy beendet
Stopped prediction by BiotechBee for Avita Therapeutics Inc.
Avita Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.00
24.06.23
24.06.23
€30.00
31.01.27
31.01.27
-27.86%
02.12.23
02.12.23
Could be very worthwhile Investment >20% year